Guselkumab

26 trials 7 recruiting LOncology

Filter these 26 trials by condition, phase, country and more.

Open in Search →

26 Registered trials

7 Recruiting

16 Completed trials

7 Sponsors

22 Countries

Phase III

Phase IV

Phase III: 14 Phase II/III: 2 Phase II: 2 Phase IV: 8

Oversight events:

1 corrective measure across 1 trial

View oversight register →

Indications tested

Crohn's disease 6 Psoriatic arthropathy 1 Psoriasis 1 Juvenile psoriatic arthritis 1 Crohn´s disease 1

Sponsors using this IMP

Janssen - Cilag International 18 Universitaetsklinikum Heidelberg AöR 2 UZ Leuven 2 Aarhus University Hospital 1 Azienda Sanitaria Universitaria Friuli Centrale 1 i-GETAID 1 Universitair Ziekenhuis Gent 1

All trials — page 2

26 total

Study to Evaluate the Efficacy, Pharmacokinetics, Safety, and Immunogenicity of Subcutaneously Administered Ustekinumab or Guselkumab in Ped… Ended

2023-507144-36-00 Phase III 7 countries Janssen - Cilag International
A Phase 3b, Randomized, Double-blind, Parallel Group, Multicenter Study to Evaluate Further Therapeutic Strategies with Guselkumab in Patien… Ended

2023-508424-34-00 Phase III 1 country Janssen Cilag International

Showing 25–26 of 26 trials

← All drugs A–Z